Research

  • Treatment-resistant Depression Study

    Treatment-resistant Depression Clinical Research Study – Now Enrolling

    Dr. Jayesh Kamath from UConn Health’s Department of Psychiatry is conducting a clinical research study of an investigational medication for adults with treatment-resistant depression (TRD).

    The purpose of this study is to evaluate the effectiveness, safety, and tolerability of the investigational medication when it is used alone in adults with TRD.  

    You may be eligible to participate if you:

    • Are 18 years of age or older
    • Have been diagnosed with TRD
    • Have not adequately responded to at least 2 different antidepressant treatments

    If you are interested, additional eligibility criteria will be assessed by the study doctor or staff. Study participation will last up to 24 weeks. 

    Qualified participants may receive investigational study medication and some study-required medical care at no cost.

    Want to learn more? Call our study coordinator at 860-679-7539.

    UCHC IRB# O21-071-2

    For more information, contact: Galina Prpich at prpich@uchc.edu